<?xml version="1.0" encoding="UTF-8"?>
<references>
<reference>
  <a1>Kalko, S.G.</a1>
  <a2>Paco, S.</a2>
  <a2>Jou, C.</a2>
  <a2>Rodríguez, M.A.</a2>
  <a2>Meznaric, M.</a2>
  <a2>Rogac, M.</a2>
  <a2>Jekovec-Vrhovsek, M.</a2>
  <a2>Sciacco, M.</a2>
  <a2>Moggio, M.</a2>
  <a2>Fagiolari, G.</a2>
  <a2>De Paepe, B.</a2>
  <a2>De Meirleir, L.</a2>
  <a2>Ferrer, I.</a2>
  <a2>Roig-Quilis, M.</a2>
  <a2>Munell, F.</a2>
  <a2>Montoya, J.</a2>
  <a2>López-Gallardo, E.</a2>
  <a2>Ruiz-Pesini, E.</a2>
  <a2>Artuch, R.</a2>
  <a2>Montero, R.</a2>
  <a2>Torner, F.</a2>
  <a2>Nascimento, A.</a2>
  <a2>Ortez, C.</a2>
  <a2>Colomer, J.</a2>
  <a2>Jimenez-Mallebrera, C.</a2>
  <t1>Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies</t1>
  <t2>BMC genomics</t2>
  <sn/>
  <op/>
  <vo/>
  <ab/>
  <la>eng</la>
  <k1/>
  <pb/>
  <pp/>
  <yr>2014</yr>
  <ed/>
  <ul>http://zaguan.unizar.es/record/61456/files/texto_completo.pdf;
	http://zaguan.unizar.es/record/61456/files/texto_completo.jpg?subformat=icon;
	</ul>
  <no>Imported from Invenio.</no>
</reference>

</references>